|
gptkbp:instance_of
|
gptkb:legal_case
|
|
gptkbp:aims_to
|
improve patient outcomes
|
|
gptkbp:analyzes
|
gptkb:dapagliflozin
|
|
gptkbp:applies_to
|
gptkb:legislation
chronic disease management
heart failure management
heart failure patients
|
|
gptkbp:approves
|
institutional review board
|
|
gptkbp:collaborated_with
|
international researchers
|
|
gptkbp:collaborations
|
various research institutions
|
|
gptkbp:completed
|
gptkb:2019
|
|
gptkbp:conducted
|
clinical settings
strict protocols
|
|
gptkbp:contributed_to
|
guidelines for heart failure treatment
|
|
gptkbp:ends_at
|
dapagliflozin is effective for heart failure
|
|
gptkbp:exhibited_at
|
reduction in heart failure hospitalization
|
|
gptkbp:fledging_period
|
18 months
|
|
gptkbp:focuses_on
|
heart failure
|
|
gptkbp:has_impact_on
|
gptkb:municipality
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
DAPA-HF study
|
|
gptkbp:includes
|
randomized controlled trial
|
|
gptkbp:involves
|
patients with heart failure
adult participants
|
|
gptkbp:is_analyzed_in
|
statistical methods
safety and efficacy
|
|
gptkbp:is_associated_with
|
improved quality of life
|
|
gptkbp:is_cited_in
|
subsequent research studies
|
|
gptkbp:is_compared_to
|
dapagliflozin vs placebo
|
|
gptkbp:is_discussed_in
|
gptkb:academic_journal
|
|
gptkbp:is_documented_in
|
clinical trial registries
|
|
gptkbp:is_evaluated_by
|
gptkb:hospital
long-term outcomes
|
|
gptkbp:is_influenced_by
|
previous studies
|
|
gptkbp:is_influential_in
|
cardiology field
|
|
gptkbp:is_part_of
|
global health initiatives
cardiovascular research
DAPA program
|
|
gptkbp:is_recognized_by
|
medical community
|
|
gptkbp:is_reviewed_by
|
peer reviewers
|
|
gptkbp:is_supported_by
|
patient advocacy groups
clinical evidence
scientific evidence
|
|
gptkbp:is_utilized_in
|
clinical decision-making
|
|
gptkbp:launched
|
gptkb:2017
|
|
gptkbp:led_to
|
principal investigator
|
|
gptkbp:measures
|
cardiovascular outcomes
|
|
gptkbp:outcome
|
all-cause mortality
change in NT-pro BNP levels
|
|
gptkbp:participants
|
multiple countries
|
|
gptkbp:published_by
|
gptkb:New_England_Journal_of_Medicine
peer-reviewed journals
medical journals
|
|
gptkbp:receives_funding_from
|
gptkb:Company
|
|
gptkbp:registration
|
gptkb:Clinical_Trials.gov
|
|
gptkbp:reports_to
|
gptkb:media_outlets
gptkb:2020
medical conferences
|
|
gptkbp:sponsor
|
gptkb:temple
|
|
gptkbp:utilizes
|
double-blind methodology
|
|
gptkbp:bfsParent
|
gptkb:Entresto
|
|
gptkbp:bfsLayer
|
4
|